Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Database
Language
Journal subject
Affiliation country
Publication year range
1.
Opt Lett ; 46(15): 3761-3764, 2021 Aug 01.
Article in English | MEDLINE | ID: mdl-34329275

ABSTRACT

A hybrid antireflective structure (ARS) is proposed for enhancing the transmittance of terahertz (THz) waves. This hybrid ARS was made by attaching a polymer-based two-layer coating onto a moth-eye structure on a silicon (Si) substrate. The measured power reflectance of this hybrid ARS remained below 6% in the frequency range of 0.6-2.5 THz, corresponding to the simulated results. The total power reflectance from 0.1 to 2.5 THz was 20% that of the unprocessed Si surface. Besides exhibiting a broadband AR characteristic, this hybrid ARS inherited the cleanable flat surface from the coating structure, which also acts as a protective shield for the moth-eye structures. This high-transmittance, cleanable, flat antireflective surface can not only improve the performance of numerous THz components but also promote the applications of THz waves in daily life.

3.
Intern Med ; 50(9): 1065-8, 2011.
Article in English | MEDLINE | ID: mdl-21532235

ABSTRACT

We report a 48-year-old man who developed rheumatoid arthritis (RA) after a successful treatment with peg-IFN-alpha plus ribavirin for chronic hepatitis C virus (HCV) infection. He had a history of smoking and a single copy of the HLA-DRB1 shared epitope (SE). In a retrospective analysis, he exhibited the anti-CCP antibodies before the start of IFN plus ribavirin treatment. However, the titers of anti-CCP antibodies and BAFF levels were elevated by the IFN plus ribavirin therapy. These observations suggest that IFN plus ribavirin therapy may work as a "trigger" for RA in genetically and environmentally predisposed individuals by affecting the cytokine network.


Subject(s)
Antiviral Agents/adverse effects , Arthritis, Rheumatoid/etiology , Interferon Type I/adverse effects , Ribavirin/adverse effects , Arthritis, Rheumatoid/immunology , Arthritis, Rheumatoid/pathology , Autoantibodies/blood , B-Cell Activating Factor/blood , Cytokines/metabolism , Hepatitis C, Chronic/drug therapy , Hepatitis C, Chronic/immunology , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Peptides, Cyclic/immunology , Recombinant Proteins , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL